ORIHEAL PETVOMI FIX INJECTION 10ML

Petvomi Fix Injection (10 ml)

Powerful injectable antiemetic for dogs and cats
This injectable formulation contains Ondansetron (2 mg/mL) and is used under direct veterinary supervision for rapid control of severe nausea and vomiting. It is especially beneficial in emergency settings or when oral dosing is impractical.

Composition

• Ondansetron Hydrochloride – 2 mg/mL, in a 10 ml vial
  (Total active content: 20 mg of Ondansetron)

Indications / Uses

Primarily used for:

• Control of vomiting due to chemotherapy

• Severe or refractory vomiting when oral medications can't be tolerated

• As part of supportive care in gastrointestinal disease, vestibular disorders, or toxin exposure

• Premedication to prevent anesthesia-related nausea under veterinary guidance
  
  

Pharmacology & Onset

• Belongs to the class of 5-HT₃ serotonin receptor antagonists, blocking signals from the gastrointestinal tract and brain’s vomiting centers.

• Effects typically manifest within 1–2 hours, offering rapid relief.
  
  

Dosage & Administration

• Administered only by a veterinarian—either intravenously (IV), intramuscularly (IM), or subcutaneously (SC)—based on the patient's condition.

• Standard IV dosage ranges from 0.1–0.5 mg/kg every 8–12 hours, adjusted per clinical response.

Safety & Side Effects

• Generally well tolerated in pets.

• Potential side effects include:

  • Drowsiness, sedation

  • Constipation or mild gastrointestinal upset

  • Head shaking

  • Rarely, arrhythmias, hypotension, or neurological signs in overdose
    
    

• Use with caution in pets with known sensitivity to ondansetron, liver impairment, or concurrent medications with pro-arrhythmic potential.

• Always monitor patient response and adjust dosage as needed.
  
  

Storage

• Store between 2 °C and 25 °C (36–77 °F).

• Protect the vial from light and maintain sterility.

Directions for Use

• Strictly for veterinary use; not for at-home administration.

• Use aseptic technique for administration as per the treating veterinarian’s protocol.

• Monitor for clinical improvement and any adverse reactions.